A
Alberto J. Espay
Researcher at University of Cincinnati
Publications - 486
Citations - 14572
Alberto J. Espay is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Parkinson's disease & Medicine. The author has an hindex of 52, co-authored 427 publications receiving 10538 citations. Previous affiliations of Alberto J. Espay include Boston University & University of Cincinnati Academic Health Center.
Papers
More filters
Journal ArticleDOI
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
C. Warren Olanow,Karl Kieburtz,Per Odin,Alberto J. Espay,David G. Standaert,Hubert H. Fernandez,Arvydas Vanagunas,Ahmed A. Othman,Katherine Widnell,Weining Z. Robieson,Yili Pritchett,Krai Chatamra,Janet Benesh,Robert A. Lenz,Angelo Antonini +14 more
TL;DR: This is the first demonstration of the benefit of continuous levodopa delivery in a double-blind controlled study and offers a promising option for control of advanced Parkinson's disease with motor complications.
Journal ArticleDOI
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke
Linda S. Williams,Joseph K. Rotich,R. Qi,N. Fineberg,Alberto J. Espay,Askiel Bruno,S. E. Fineberg,W. R. Tierney +7 more
TL;DR: Admitting hyperglycemia was common among patients with acute ischemic stroke and was associated with increased short- and long-term mortality and with increased inpatient charges.
Journal ArticleDOI
Technology in Parkinson's disease: Challenges and opportunities.
Alberto J. Espay,Paolo Bonato,Fatta B. Nahab,Walter Maetzler,John Dean,Jochen Klucken,Bjoern M. Eskofier,Aristide Merola,Fay B. Horak,Anthony E. Lang,Ralf Reilmann,Joseph P. Giuffrida,Alice Nieuwboer,Malcolm K. Horne,Max A. Little,Irene Litvan,Tanya Simuni,E. Ray Dorsey,Michelle A. Burack,Ken Kubota,Anita Kamondi,Catarina Godinho,Jean-Francois Daneault,Georgia Mitsi,Lothar Krinke,J.M. Hausdorff,Bastiaan R. Bloem,Spyros Papapetropoulos +27 more
TL;DR: The work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD is summarized.
Journal ArticleDOI
Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.
Alberto J. Espay,Selma Aybek,Alan Carson,Mark J. Edwards,Laura H. Goldstein,Mark Hallett,Kathrin LaFaver,W. Curt LaFrance,Anthony E. Lang,Timothy R Nicholson,Glenn Nielsen,Markus Reuber,Valerie Voon,Jon Stone,Francesca Morgante,Francesca Morgante +15 more
TL;DR: The new model highlights a wider range of past sensitizing events, such as physical trauma, medical illness, or physiological/psychophysiological events, that correlate with abnormal predictions of sensory data and body-focused attention.
Journal ArticleDOI
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Ju-Hee Kang,Ju-Hee Kang,David J. Irwin,Alice Chen-Plotkin,Andrew Siderowf,Chelsea Caspell,Christopher S. Coffey,Teresa Waligorska,Peggy Taylor,Sarah Pan,Mark Frasier,Kenneth Marek,Karl Kieburtz,Danna Jennings,Tanya Simuni,Caroline M. Tanner,Andrew B. Singleton,Arthur W. Toga,Sohini Chowdhury,Brit Mollenhauer,John Q. Trojanowski,Leslie M. Shaw,Shirley Lasch,Emily Flagg,Werner Poewe,Todd Sherer,Claire Meunier,Alice Rudolph,Cindy Casaceli,John Seibyl,Susan Mendick,Norbert Schuff,Liz Uribe,Jon W. Yankey,Karen Crawford,Alison Scutti,Paola Casalin,Giulia Malferrari,Keith A. Hawkins,David W. Russell,Laura Leary,Stewart A. Factor,Barbara Sommerfeld,Penelope Hogarth,Emily Pighetti,Karen Williams,David Standaert,Stephanie Guthrie,Robert A. Hauser,Joseph Jankovic,Christine Hunter,Matthew B. Stern,Abigail Darin,James B. Leverenz,Marne Baca,Sam Frank,Cathi-Ann Thomas,Irene Richard,Cheryl Deeley,Linda Rees,Fabienne Sprenger,Wolfgang Oertel,Diana Willeke,Holly A. Shill,Hubert H. Fernandez,Jennifer Mule,Daniela Berg,Katharina Gauss,Douglas Galasko,Deborah Fontaine,Zoltan Mari,Arita McCoy,David Brooks,Bina Shah,Paolo Barone,Stuart Isaacson,Angela James,Alberto J. Espay,Kristy J. Espay,Dominic B. Rowe,Madelaine Ranola +80 more
TL;DR: It is found that measures of CSF Aβ1-42, T-t Tau, P-tau181, and α-synuclein have prognostic and diagnostic potential in early-stage PD.